Performance Shipping highlights $535 million secured revenue backlog in investor presentation
Bitget2026/11/04 08:40Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
- Performance Shipping reported $535 million in secured charter revenue as of June 30, 2026, with 3.4 years of average remaining employment.
- Fixed charter coverage is approximately 100% for the remaining six months of 2026 and full-year 2027, falling to approximately 90% in 2028.
- Remaining newbuilding capital expenditures totaled $175.3 million, covered approximately 3.1 times by secured revenue.
- Committed financing totals $172.4 million for four of six newbuilds; financing for two Suezmax tankers remains to be arranged.
- The remaining LR1 tanker is scheduled for delivery in January 2027, followed by Suezmax deliveries in October 2028 and May 2029.
Disclaimer:
This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Performance Shipping Inc. published the original content used to generate this news brief on November 04, 2026, and is solely responsible for the information contained therein.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like
Canaccord Genuity: Lowers Oklo's target price to $66
格隆汇•2026/11/09 07:01

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.
Dental treatment company vVardis has announced the terms for its $214 million US IPO.
智通财经•2026/11/09 06:41

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss
Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.
智通财经•2026/11/09 06:41

Crypto prices
MoreBitcoin
BTC
$73,942.18
-2.38%
Ethereum
ETH
$2,092.64
-6.25%
Tether USDt
USDT
$0.9987
+0.02%
BNB
BNB
$677.68
-2.86%
USDC
USDC
$0.9998
+0.00%
XRP
XRP
$1.09
-6.43%
Solana
SOL
$85.49
-3.96%
TRON
TRX
$0.3164
-1.20%
Zcash
ZEC
$1,199.7
-5.04%
Hyperliquid
HYPE
$73.48
-4.81%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now